focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,772.50
Bid: 1,772.00
Ask: 1,772.50
Change: -11.00 (-0.62%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Barclays Downgrades Zoopla To Equal Weight

Thu, 21st Apr 2016 08:31

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
JEFFERIES RAISES LAND SECURITIES PRICE TARGET TO 975 (957) PENCE - 'HOLD'
----------
JEFFERIES CUTS INTU PROPERTIES PRICE TARGET TO 240 (247) PENCE - 'UNDERPERFORM'
----------
JEFFERIES CUTS HAMMERSON PRICE TARGET TO 473 (493) PENCE - 'UNDERPERFORM'
----------
JEFFERIES CUTS BRITISH LAND PRICE TARGET TO 570 (615) PENCE - 'UNDERPERFORM'
----------
EXANE BNP RAISES GLAXOSMITHKLINE PRICE TARGET TO 1430 (1350) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY RAISES GLAXOSMITHKLINE PRICE TARGET TO 1500 (1450) PENCE - 'EQUALWEIGHT'
----------
CITIGROUP RAISES ARM HOLDINGS PRICE TARGET TO 1060 (1045) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES BHP BILLITON PRICE TARGET TO 780 (665) PENCE - 'UNDERWEIGHT'
----------
HSBC RAISES SHELL PRICE TARGET TO 2000 (1925) PENCE - 'BUY'
----------
HSBC RAISES BP PRICE TARGET TO 410 (405) PENCE - 'BUY'
----------
GOLDMAN RAISES BUNZL PRICE TARGET TO 1800 (1780) PENCE - 'SELL'
----------
GOLDMAN RAISES RECKITT BENCKISER PRICE TARGET TO 6680 (6640) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES WOLSELEY PRICE TARGET TO 4400 (4300) PENCE - 'BUY'
----------
CHARLES STANLEY RAISES AB FOODS TO 'HOLD' ('REDUCE')
----------
MORGAN STANLEY RAISES SAGE GROUP PRICE TARGET TO 470 (440)P - 'UNDERWEIGHT'
----------
FTSE 250
----------
BARCLAYS CUTS ZOOPLA TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 295 (270) PENCE
----------
PANMURE CUTS AVEVA GROUP PRICE TARGET TO 1864 (1910) PENCE - 'HOLD'
----------
MORGAN STANLEY RAISES AVEVA GROUP TARGET TO 1,240 (1,150)P - 'UNDERWEIGHT'
----------
JEFFERIES CUTS WORKSPACE GROUP PRICE TARGET TO 765 (804) PENCE - 'HOLD'
----------
JEFFERIES RAISES UNITE GROUP PRICE TARGET TO 575 (569) PENCE - 'HOLD'
----------
JEFFERIES RAISES SHAFTESBURY PRICE TARGET TO 888 (801) PENCE - 'HOLD'
----------
JEFFERIES CUTS SEGRO PRICE TARGET TO 380 (414) PENCE - 'HOLD'
----------
JEFFERIES RAISES LONDONMETRIC PROPERTY PRICE TARGET TO 165 (153) PENCE - 'HOLD'
----------
JEFFERIES CUTS HANSTEEN PRICE TARGET TO 110 (115) PENCE - 'HOLD'
----------
JEFFERIES CUTS GREAT PORTLAND PRICE TARGET TO 668 (705) PENCE - 'HOLD'
----------
JEFFERIES CUTS GRAINGER PRICE TARGET TO 215 (240) PENCE - 'HOLD'
----------
JEFFERIES CUTS DERWENT LONDON PRICE TARGET TO 2950 (3055) PENCE - 'HOLD'
----------
JEFFERIES RAISES BIG YELLOW GROUP PRICE TARGET TO 725 (654) PENCE - 'HOLD'
----------
JEFFERIES CUTS PETROFAC TO 'HOLD' ('BUY')
----------
CREDIT SUISSE RAISES SERCO GROUP PRICE TARGET TO 100 (95) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS VICTREX TO 'HOLD' ('BUY') - TARGET 1620 (1800) PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.